| 名稱 | FCGR2B/HEK293 |
| 型號 | CBP74078 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FCGR2B/HEK293，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 【產(chǎn)品推介】T細(xì)胞活化篩選模型
- 細(xì)胞株有關(guān)細(xì)胞培養(yǎng)污染的控制
- 細(xì)胞因子風(fēng)暴和自身免疫性炎癥治療新靶點(diǎn)GM-CSF
- 抗衰老全新靶點(diǎn)，抑制IL-11通路可延長哺乳動物壽命
- Canine IL-31細(xì)胞篩選模型
- 5月是黑色素瘤意識月，盤點(diǎn)黑色素瘤研究進(jìn)展
- ATCC細(xì)胞的實(shí)驗(yàn)要點(diǎn)及說明
- HPV分子診斷標(biāo)準(zhǔn)品擴(kuò)容：精準(zhǔn)檢測，實(shí)力升級
- 基因守護(hù)者：抑癌基因TP53
- 心衰治療靶點(diǎn)：BNP/NPR1
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74078FCGR2B/HEK293
- 詳細(xì)內(nèi)容
| CBP74078 | |
| I. Background | |
| The protein encoded by this gene is a low affinity receptor for the Fc region of immunoglobulin gamma complexes. The encoded protein is involved in the phagocytosis of immune complexes and in the regulation of antibody production by B-cells. Variations in this gene may increase susceptibilty to systemic lupus erythematosus (SLE). Several transcript variants encoding different isoforms have been found for this gene. | |
| II. Description | |
Recombinant HEK293 cells constitutively expressing human FCGR2B. | |
| III. Introduction | |
| Host Cell: | HEK293 |
| Expressed gene: | FCGR2B（FcγRIIb） |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Synonym(s): | CD32B, FCG2, Fc gamma receptor, Fcgamma receptor |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | DMEM +10%FBS+100ug/ml Hygromycin B |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Binding Assay,FACS |
| IV. Description of Host Cell Line | |
| Organism: | Human |
| Tissue: | kidney |
| Morphology: | Epitheloid cell |
| Growth Properties: | Adherent |
| Ⅴ. Representative Data | |
Figure 1.Recombinant HEK293 cells constitutively expressing FCGR2B(FcγRIIb). | |
